161 related articles for article (PubMed ID: 27340776)
1. SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells.
Gwak J; Shin JY; Lee K; Hong SK; Oh S; Goh SH; Kim WS; Ju BG
Oncotarget; 2016 Jul; 7(30):48250-48264. PubMed ID: 27340776
[TBL] [Abstract][Full Text] [Related]
2. Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2.
Lee K; Na W; Maeng JH; Wu H; Ju BG
J Biosci; 2013 Mar; 38(1):105-12. PubMed ID: 23385818
[TBL] [Abstract][Full Text] [Related]
3. SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer.
Gwak J; Jeong H; Lee K; Shin JY; Sim T; Na J; Kim J; Ju BG
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32971847
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
5. HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.
Wang H; Liu G; Shen D; Ye H; Huang J; Jiao L; Sun Y
Oncol Rep; 2015 Sep; 34(3):1203-10. PubMed ID: 26135141
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
8. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
11. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract][Full Text] [Related]
12. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
[TBL] [Abstract][Full Text] [Related]
13. Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression.
Chen CM; Lin CL; Chiou HL; Hsieh SC; Lin CL; Cheng CW; Hung CH; Tsai JP; Hsieh YH
Oncotarget; 2017 Feb; 8(8):13886-13897. PubMed ID: 28108731
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
15. [LASS2/TMSG1 gene silencing promotes the invasiveness and metastatic of human prostatic carcinoma cells through increase in vacuolar ATPase activity].
Xu X; You J; Pei F
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):177-83. PubMed ID: 24842017
[TBL] [Abstract][Full Text] [Related]
16. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.
Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH
Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453
[TBL] [Abstract][Full Text] [Related]
17. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
18. SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.
Bloom JE; McNeel DG
Oncotarget; 2016 Aug; 7(32):50997-51011. PubMed ID: 27276714
[TBL] [Abstract][Full Text] [Related]
19. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
20. GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer.
Su W; Li S; Chen X; Yin L; Ma P; Ma Y; Su B
Oncotarget; 2017 Jan; 8(3):4449-4459. PubMed ID: 27966458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
